These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 10589060

  • 1. Maternal serum superoxide dismutase (SOD): a possible marker for screening Down syndrome affected pregnancies.
    Ognibene A, Ciuti R, Tozzi P, Messeri G.
    Prenat Diagn; 1999 Nov; 19(11):1058-60. PubMed ID: 10589060
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Are Down syndrome fetuses detected through maternal serum screening similar to those remaining undetected?
    Christiaens GC, Hagenaars AM, Akkerman C, De France HF.
    Prenat Diagn; 1996 May; 16(5):437-42. PubMed ID: 8844002
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Serum screening of pregnant women reveals Down syndrome. Analysis of biochemical markers for earlier detection].
    Christiansen M, Larsen SO, Nørgaard-Pedersen B.
    Lakartidningen; 1997 Dec 17; 94(51-52):4898-902. PubMed ID: 9454010
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fetal gender impact on multiple-marker screening results.
    Bazzett LB, Yaron Y, O'Brien JE, Critchfield G, Kramer RL, Ayoub M, Johnson MP, Evans MI.
    Am J Med Genet; 1998 Apr 13; 76(5):369-71. PubMed ID: 9556293
    [Abstract] [Full Text] [Related]

  • 16. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
    Muller F, Dreux S, Dupoizat H, Uzan S, Dubin MF, Oury JF, Dingeon B, Dommergues M.
    Prenat Diagn; 2003 Apr 13; 23(4):331-5. PubMed ID: 12673641
    [Abstract] [Full Text] [Related]

  • 17. Second trimester serum markers.
    Canick JA, MacRae AR.
    Semin Perinatol; 2005 Aug 13; 29(4):203-8. PubMed ID: 16104669
    [Abstract] [Full Text] [Related]

  • 18. [Maternal serum screening for Down syndrome and neural tube defects].
    van Rijn M, Christiaens GC, van der Schouw YT, Hagenaars AM, de Pater JM, Visser GH.
    Ned Tijdschr Geneeskd; 1998 Feb 21; 142(8):409-15. PubMed ID: 9562776
    [Abstract] [Full Text] [Related]

  • 19. Triploidy identified through second-trimester serum screening.
    Huang T, Alberman E, Wald N, Summers AM.
    Prenat Diagn; 2005 Mar 21; 25(3):229-33. PubMed ID: 15791661
    [Abstract] [Full Text] [Related]

  • 20. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
    Maymon R, Cuckle H, Jones R, Reish O, Sharony R, Herman A.
    Prenat Diagn; 2005 Dec 21; 25(12):1102-6. PubMed ID: 16231324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.